Sort   by:  
 Page size 
UnknownVirus-like particle display of HER2 induces potent anti-cancer responses.
Not available
S-EPMC5790387 | biostudies-literature
UnknownInnovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma.
Not available
S-EPMC10416854 | biostudies-literature
UnknownCancer immunoprevention: from mice to early clinical trials.
Not available
S-EPMC6003025 | biostudies-literature
UnknownSynovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research.
Not available
S-EPMC9913760 | biostudies-literature
UnknownIL-1 Family Members in Bone Sarcomas.
Not available
S-EPMC10854900 | biostudies-literature
UnknownHER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.
Not available
S-EPMC8305095 | biostudies-literature
UnknownIFN-γ and CD38 in Hyperprogressive Cancer Development.
Not available
S-EPMC7830527 | biostudies-literature
UnknownInhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
Not available
S-EPMC2684841 | biostudies-literature
UnknownMetformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
Not available
S-EPMC3877110 | biostudies-literature
UnknownCRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
Not available
S-EPMC9559017 | biostudies-literature
Sort   by:  
 Page size